AR104265A1 - Combinación de al menos un inhibidor de proteasa y al menos un principio activo para su uso en la prevención y/o tratamiento de lesiones de piel - Google Patents
Combinación de al menos un inhibidor de proteasa y al menos un principio activo para su uso en la prevención y/o tratamiento de lesiones de pielInfo
- Publication number
- AR104265A1 AR104265A1 ARP160101022A ARP160101022A AR104265A1 AR 104265 A1 AR104265 A1 AR 104265A1 AR P160101022 A ARP160101022 A AR P160101022A AR P160101022 A ARP160101022 A AR P160101022A AR 104265 A1 AR104265 A1 AR 104265A1
- Authority
- AR
- Argentina
- Prior art keywords
- prevention
- treatment
- combination
- protease inhibitor
- active principle
- Prior art date
Links
- 230000002265 prevention Effects 0.000 title abstract 3
- 229940124158 Protease/peptidase inhibitor Drugs 0.000 title abstract 2
- 239000000137 peptide hydrolase inhibitor Substances 0.000 title abstract 2
- 208000028990 Skin injury Diseases 0.000 title 1
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 abstract 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 abstract 2
- 239000004480 active ingredient Substances 0.000 abstract 2
- 231100000444 skin lesion Toxicity 0.000 abstract 2
- 206010040882 skin lesion Diseases 0.000 abstract 2
- 244000144927 Aloe barbadensis Species 0.000 abstract 1
- 235000002961 Aloe barbadensis Nutrition 0.000 abstract 1
- 235000005881 Calendula officinalis Nutrition 0.000 abstract 1
- LZZYPRNAOMGNLH-UHFFFAOYSA-M Cetrimonium bromide Chemical compound [Br-].CCCCCCCCCCCCCCCC[N+](C)(C)C LZZYPRNAOMGNLH-UHFFFAOYSA-M 0.000 abstract 1
- 235000004866 D-panthenol Nutrition 0.000 abstract 1
- 239000011703 D-panthenol Substances 0.000 abstract 1
- 241000196324 Embryophyta Species 0.000 abstract 1
- 244000068988 Glycine max Species 0.000 abstract 1
- 235000010469 Glycine max Nutrition 0.000 abstract 1
- 240000007594 Oryza sativa Species 0.000 abstract 1
- 235000007164 Oryza sativa Nutrition 0.000 abstract 1
- 102000035195 Peptidases Human genes 0.000 abstract 1
- 108091005804 Peptidases Proteins 0.000 abstract 1
- 244000046052 Phaseolus vulgaris Species 0.000 abstract 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 abstract 1
- 239000004365 Protease Substances 0.000 abstract 1
- 244000061456 Solanum tuberosum Species 0.000 abstract 1
- 235000002595 Solanum tuberosum Nutrition 0.000 abstract 1
- 240000000785 Tagetes erecta Species 0.000 abstract 1
- 239000002671 adjuvant Substances 0.000 abstract 1
- 235000011399 aloe vera Nutrition 0.000 abstract 1
- 229960000686 benzalkonium chloride Drugs 0.000 abstract 1
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 abstract 1
- 229960002798 cetrimide Drugs 0.000 abstract 1
- VNFPBHJOKIVQEB-UHFFFAOYSA-N clotrimazole Chemical compound ClC1=CC=CC=C1C(N1C=NC=C1)(C=1C=CC=CC=1)C1=CC=CC=C1 VNFPBHJOKIVQEB-UHFFFAOYSA-N 0.000 abstract 1
- 229960004022 clotrimazole Drugs 0.000 abstract 1
- 229960003949 dexpanthenol Drugs 0.000 abstract 1
- 229940008099 dimethicone Drugs 0.000 abstract 1
- 235000013870 dimethyl polysiloxane Nutrition 0.000 abstract 1
- 239000004205 dimethyl polysiloxane Substances 0.000 abstract 1
- 235000013399 edible fruits Nutrition 0.000 abstract 1
- 230000002550 fecal effect Effects 0.000 abstract 1
- 210000003608 fece Anatomy 0.000 abstract 1
- 229960000988 nystatin Drugs 0.000 abstract 1
- VQOXZBDYSJBXMA-NQTDYLQESA-N nystatin A1 Chemical compound O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1/C=C/C=C/C=C/C=C/CC/C=C/C=C/[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 VQOXZBDYSJBXMA-NQTDYLQESA-N 0.000 abstract 1
- 229940101267 panthenol Drugs 0.000 abstract 1
- 235000020957 pantothenol Nutrition 0.000 abstract 1
- 239000011619 pantothenol Substances 0.000 abstract 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 abstract 1
- 235000012015 potatoes Nutrition 0.000 abstract 1
- 235000009566 rice Nutrition 0.000 abstract 1
- 210000002700 urine Anatomy 0.000 abstract 1
- 239000011787 zinc oxide Substances 0.000 abstract 1
- 229960001296 zinc oxide Drugs 0.000 abstract 1
- 235000014692 zinc oxide Nutrition 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/55—Protease inhibitors
- A61K38/56—Protease inhibitors from plants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/164—Amides, e.g. hydroxamic acids of a carboxylic acid with an aminoalcohol, e.g. ceramides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4174—Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/695—Silicon compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/30—Zinc; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/886—Aloeaceae (Aloe family), e.g. aloe vera
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Dermatology (AREA)
- Inorganic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Abstract
Combinación que comprende al menos un inhibidor de proteasa, que puede ser diferentes orígenes, tal como plantas, frutas, salvado de arroz, semillas de frijol, soja o papa y al menos un principio activo adicional, seleccionado de óxido de zinc, dexpantenol, pantenol, cloruro de benzalconio, cetrimida, clotrimazol, nistatina, dimeticona, aloe vera, o caléndula y a su uso en la prevención y/o tratamiento de lesiones de piel causadas por orina y/o heces y como adyuvante en la reparación de piel. Combinación en asociación con principios activos adicionales y a su uso en la prevención y/o tratamiento de lesiones de piel causadas por proteasas en las heces y como adyuvante en la reparación de piel.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/EP2015/058451 WO2016165783A1 (en) | 2015-04-17 | 2015-04-17 | Combination of at least one protease inhibitor and at least one active principle for use in the prevention and/or treatment of skin lesions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR104265A1 true AR104265A1 (es) | 2017-07-05 |
Family
ID=52988064
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP160101022A AR104265A1 (es) | 2015-04-17 | 2016-04-14 | Combinación de al menos un inhibidor de proteasa y al menos un principio activo para su uso en la prevención y/o tratamiento de lesiones de piel |
Country Status (18)
| Country | Link |
|---|---|
| EP (1) | EP3283093B1 (es) |
| KR (1) | KR102359285B1 (es) |
| CN (1) | CN107683144B (es) |
| AR (1) | AR104265A1 (es) |
| BR (1) | BR112017022286A2 (es) |
| CO (1) | CO2017010543A2 (es) |
| DK (1) | DK3283093T3 (es) |
| ES (1) | ES2830379T3 (es) |
| HK (1) | HK1246205A1 (es) |
| HR (1) | HRP20201777T1 (es) |
| HU (1) | HUE052035T2 (es) |
| MX (1) | MX2017013352A (es) |
| MY (1) | MY196133A (es) |
| PH (1) | PH12017501889A1 (es) |
| PT (1) | PT3283093T (es) |
| RS (1) | RS61576B1 (es) |
| SG (1) | SG11201708214UA (es) |
| WO (1) | WO2016165783A1 (es) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112402273B (zh) * | 2020-12-01 | 2023-10-03 | 金发拉比妇婴童用品股份有限公司 | 一种改善婴幼儿红屁股的膏霜及其制备方法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TR200002601T2 (tr) * | 1998-03-12 | 2000-12-21 | The Procter & Gamble Company | Bir enzim inhibitörünü ihtiva eden bir cilt bakım bileşimine sahip olan kullanılıp atılabilir emici eşya. |
| EP0958833A1 (en) * | 1998-05-20 | 1999-11-24 | Erasmus Universiteit Rotterdam | Methods and means for preventing or treating inflammation |
| US6207596B1 (en) * | 1998-11-09 | 2001-03-27 | The Procter & Gamble Company | Disposable premoistened wipe containing an antimicrobial protease inhibitor |
| US7005557B2 (en) * | 2001-07-03 | 2006-02-28 | The Procter & Gamble Company | Film-forming compositions for protecting skin from body fluids and articles made therefrom |
| US20050175719A1 (en) * | 2004-02-05 | 2005-08-11 | Ying Sun | Procyanidins for treatment and prevention of enzymatic irritation to the skin |
| EP1586336A1 (en) * | 2004-04-06 | 2005-10-19 | JOHNSON & JOHNSON GmbH | Compositions containing copper salts and soy products |
| NZ547991A (en) * | 2005-06-22 | 2008-08-29 | Bristol Myers Squibb Co | Enzyme inhibiting sprayable skin barrier compositions comprising enzyme inhibitors derived from potatoes |
-
2015
- 2015-04-17 BR BR112017022286A patent/BR112017022286A2/pt not_active Application Discontinuation
- 2015-04-17 ES ES15717170T patent/ES2830379T3/es active Active
- 2015-04-17 SG SG11201708214UA patent/SG11201708214UA/en unknown
- 2015-04-17 KR KR1020177031864A patent/KR102359285B1/ko active IP Right Grant
- 2015-04-17 DK DK15717170.3T patent/DK3283093T3/da active
- 2015-04-17 EP EP15717170.3A patent/EP3283093B1/en active Active
- 2015-04-17 CN CN201580078893.4A patent/CN107683144B/zh active Active
- 2015-04-17 WO PCT/EP2015/058451 patent/WO2016165783A1/en active Application Filing
- 2015-04-17 HU HUE15717170A patent/HUE052035T2/hu unknown
- 2015-04-17 MY MYPI2017703833A patent/MY196133A/en unknown
- 2015-04-17 MX MX2017013352A patent/MX2017013352A/es unknown
- 2015-04-17 PT PT157171703T patent/PT3283093T/pt unknown
- 2015-04-17 RS RS20201331A patent/RS61576B1/sr unknown
-
2016
- 2016-04-14 AR ARP160101022A patent/AR104265A1/es not_active Application Discontinuation
-
2017
- 2017-10-13 CO CONC2017/0010543A patent/CO2017010543A2/es unknown
- 2017-10-18 PH PH12017501889A patent/PH12017501889A1/en unknown
-
2018
- 2018-05-08 HK HK18105937.5A patent/HK1246205A1/zh unknown
-
2020
- 2020-11-04 HR HRP20201777TT patent/HRP20201777T1/hr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP3283093B1 (en) | 2020-09-16 |
| HUE052035T2 (hu) | 2021-04-28 |
| MY196133A (en) | 2023-03-16 |
| MX2017013352A (es) | 2018-06-22 |
| RS61576B1 (sr) | 2021-04-29 |
| SG11201708214UA (en) | 2017-11-29 |
| KR20180003553A (ko) | 2018-01-09 |
| WO2016165783A1 (en) | 2016-10-20 |
| DK3283093T3 (da) | 2020-11-09 |
| CO2017010543A2 (es) | 2018-03-09 |
| BR112017022286A2 (pt) | 2018-07-10 |
| CN107683144A (zh) | 2018-02-09 |
| HK1246205A1 (zh) | 2018-09-07 |
| ES2830379T3 (es) | 2021-06-03 |
| KR102359285B1 (ko) | 2022-02-07 |
| CN107683144B (zh) | 2020-08-07 |
| EP3283093A1 (en) | 2018-02-21 |
| PT3283093T (pt) | 2020-11-03 |
| PH12017501889A1 (en) | 2018-03-05 |
| HRP20201777T1 (hr) | 2021-01-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CL2021000415A1 (es) | Vesículas derivadas de lactobacillus paracasei y uso de las mismas | |
| CL2020000220A1 (es) | Composiciones que comprenden aminoácidos para su uso en el tratamiento de enfermedades relacionadas con la disfunción mitocondrial. | |
| WO2016118951A3 (en) | Heterocyclic itk inhibitors for treating inflammation and cancer | |
| CL2017002825A1 (es) | Formulaciones de tpp1 y métodos para tratar la enfermedad de cln2 | |
| CR9816A (es) | Composicion sinergetica y metodo de uso | |
| WO2015066302A3 (en) | Compositions, methods of use, and methods of treatment | |
| WO2015026494A3 (en) | Methods for treating tissue fibrosis | |
| BR112019006880A2 (pt) | compostos e composições para tratamento de leishmaniose e métodos de diagnóstico e tratamen-to usando os mesmos | |
| BR112012015386B8 (pt) | composição oftálmica tópica | |
| CL2020000221A1 (es) | Composiciones que comprenden aminoácidos para su uso en el tratamiento de enfermedades relacionadas con la disfunción mitocondrial. | |
| AR104265A1 (es) | Combinación de al menos un inhibidor de proteasa y al menos un principio activo para su uso en la prevención y/o tratamiento de lesiones de piel | |
| CL2017002630A1 (es) | Combinación de al menos un inhibidor de proteasa y al menos un principio activo para su uso en la prevención y/o tratamiento de lesiones de piel | |
| DOP2017000238A (es) | Combinación de al menos un inhibidor de proteasa y al menos un principio activo para su uso en la prevención y/o tratamiento de lesiones de piel | |
| AR064214A1 (es) | Uso de epotilonas en el tratamiento de la osteoporosis y enfermedades relacionadas | |
| GB2595323B (en) | Hair treatment products based on biodegradable active ingredients | |
| PE20180161A1 (es) | Combinacion de al menos un inhibidor de proteasa y al menos un principio activo para su uso en la prevencion y/o tratamiento de lesiones de piel | |
| TH1701006167A (th) | สารรวมของอย่างน้อยที่สุดหนึ่งตัวยับยั้งโปรตีเอส และอย่างน้อยที่สุดหนึ่งสารออกฤทธิ์สำหรับการใช้ในการป้องกัน และ/หรือ การรักษารอยโรคที่ผิวหนัง | |
| ES2529390A1 (es) | Dispositivo para el tratamiento de un tejido mediante radiación láser | |
| BR112017020100A2 (pt) | composições herbicidas compreendendo isoxaflutol e diflufenican | |
| IT201700063112A1 (it) | Formulazione per uso orale comprendente olio ozonizzato nella prevenzione e/o trattamento di lesioni cutanee causate dall’esposizione a radiazioni ionizzanti e/o trattamento chemioterapico. | |
| WO2015200601A3 (en) | Lymphangiogenesis inhibitors for cancer and for graft survival | |
| GB2583876B (en) | Wetness indicating compositions including an amphiphilic polydiacetylene and absorbent articles including the same | |
| WO2015004475A3 (en) | Compositions comprising beta-catenin inhibitors for treating spinal muscular atrophy | |
| 大島康子 | Characteristics of IgA nephropathy in advanced‑age patients | |
| CL2019003277A1 (es) | Composición cosmética de textura oleosa, uso y método para prevención y/o tratamiento de las señales de envejecimiento externo y del estrés cutáneo. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC | Refusal |